Merck to pay as much as $22 billion for Daiichi Sankyo's cancer drugs

Retrieved on: 2023-10-21 16:34:32

Tags for this article:

Click the tags to see associated articles and topics

Merck to pay as much as $22 billion for Daiichi Sankyo's cancer drugs. View article details on hiswai:

Excerpt

Daiichi has already teamed up with AstraZeneca Plc to sell a similar drug called Enhertu that's used to treat breast cancer and is on track to ...

Article found on: www.spokesman.com